Rock Springs Capital Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Buy |
701,408
+235,537
| +51% | +$4.72M | 0.88% | 41 |
|
|
2025
Q1 | $9.17M | Buy |
465,871
+37,300
| +9% | +$734K | 0.52% | 54 |
|
|
2024
Q4 | $9.64M | Hold |
428,571
| – | – | 0.37% | 63 |
|
|
2024
Q3 | $10.9M | Hold |
428,571
| – | – | 0.36% | 63 |
|
|
2024
Q2 | $10M | Hold |
428,571
| – | – | 0.3% | 69 |
|
|
2024
Q1 | $7.54M | Buy |
+428,571
| New | +$7.54M | 0.19% | 83 |
|
|
2022
Q4 | – | Sell |
-210,601
| Closed | -$1.92M | – | 122 |
|
|
2022
Q3 | $1.92M | Hold |
210,601
| – | – | 0.05% | 113 |
|
|
2022
Q2 | $1.03M | Hold |
210,601
| – | – | 0.03% | 126 |
|
|
2022
Q1 | $1.58M | Buy |
210,601
+25
| +0% | +$188 | 0.04% | 126 |
|
|
2021
Q4 | $1.9M | Buy |
210,576
+3,300
| +2% | +$29.7K | 0.04% | 129 |
|
|
2021
Q3 | $3.38M | Buy |
+207,276
| New | +$3.38M | 0.07% | 135 |
|
|
2021
Q1 | – | Sell |
-90,125
| Closed | -$7.95M | – | 157 |
|
|
2020
Q4 | $7.95M | Buy |
90,125
+389
| +0.4% | +$34.3K | 0.17% | 121 |
|
|
2020
Q3 | $7.3M | Sell |
89,736
-1,447
| -2% | -$118K | 0.19% | 115 |
|
|
2020
Q2 | $10.1M | Sell |
91,183
-20,301
| -18% | -$2.24M | 0.28% | 104 |
|
|
2020
Q1 | $7.15M | Buy |
+111,484
| New | +$7.15M | 0.3% | 88 |
|